Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2026-525783-18-00Phase 3Authorised
Phase 3 trial of sufentanil and fentanyl in acute cholecystitis (2 arms), sponsored by Fundación Biomédica Galicia Sur. Primary endpoint: Visual Analogue Scale (VAS). Planned start Jun 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2026-525783-18-00.